The Board aims to reduce the risk of people developing dust diseases and to optimise health and care outcomes for people with a dust disease and their families.
A total of 55 grants with a funded value of over $13 million were approved by the Dust Diseases Board between 2016 and 2023.
The Dust Diseases Summary of Impact Assessment is now available.
To make a positive difference to those impacted by hazardous dust exposure and dust diseases.
The Dust Diseases Board will deliver this by:
- Funding research and other activities into the causes, mechanisms, diagnosis, treatment and prevention of dust diseases, to reduce the risk of people developing a dust disease and to optimise health and care outcomes for people with a dust disease.
- Funding organisations that support people with a dust disease and their families, to inform and educate people about dust diseases and the dust diseases scheme; support people through the compensation process; and optimise the wellbeing of people with a dust disease.
Dust Diseases Board members
John Walsh AO
John is Chair of the Dust Diseases Board, a Non-Executive Director of the icare Board, a Member of the Board Audit Committee and the Board Risk Committee.
Professor Sanchia Aranda AM
Sanchia was most recently CEO of Cancer Council Australia (2015-2021) and has worked in cancer control for over 40 years.
Sylvia Kidziak AM
Sylvia has over 30 years' experience in the field of asbestos-related research, workplace safety and stakeholder engagement.
Ray is an Advisory Board member of Fundsquire Pty Ltd and Director of Prudential Group Holdings and Squirrel Superannuation Services.
Sherri is a senior Legal/Industrial Officer for the CFMEU NSW Branch with 12 years of service at the branch.
Peter is the Chair of the Asbestos Diseases Research Foundation (ADRF) Board, Deputy Chair of EE-Oz Energy Skills Australia and a member of the Board of Exemplar Systems Pty Ltd and Exemplar Learning Pty Ltd.